Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,076 | 20,215 | 20,158 | 14,907 | 18,833 |
| Marketable Securities | 46,366 | 63,013 | 57,570 | 59,093 | 30,190 |
| Receivables | 12 | 46,646 | N/A | 4 | 14 |
| Other current assets | 0 | 0 | 5 | 0 | 0 |
| TOTAL | $113,107 | $131,131 | $79,338 | $76,427 | $51,140 |
| Non-Current Assets | |||||
| PPE Net | 1,751 | 1,637 | 1,221 | 997 | 1,310 |
| Investments And Advances | 179 | 0 | 2,502 | 0 | 0 |
| Other Non-Current Assets | 200 | 200 | 127 | 127 | 323 |
| TOTAL | $2,130 | $1,837 | $3,850 | $1,124 | $1,633 |
| Total Assets | $115,237 | $132,968 | $83,188 | $77,551 | $52,773 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 152 |
| Accounts payable and accrued liabilities | 2,238 | 1,361 | 3,709 | 2,152 | 1,208 |
| Accrued Expenses | 8,421 | 5,400 | 8,272 | 4,877 | 3,232 |
| TOTAL | $31,649 | $23,855 | $26,704 | $7,105 | $4,592 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,639 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 20,990 | 17,094 | 14,723 | 76 | N/A |
| TOTAL | $14,998 | $17,049 | $2,042 | $361 | $3 |
| Total Liabilities | $46,647 | $40,904 | $28,746 | $7,466 | $4,595 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,593 | 38,675 | 36,078 | 24,082 | 12,732 |
| Common Shares | 40 | 39 | 31 | 24 | 75 |
| Retained earnings | -534,744 | -497,243 | -482,597 | -448,880 | -408,510 |
| Other shareholders' equity | 149 | -4 | 7 | 18 | 3 |
| TOTAL | $68,590 | $92,064 | $54,442 | $70,085 | $48,178 |
| Total Liabilities And Equity | $115,237 | $132,968 | $83,188 | $77,551 | $52,773 |